Related Experiment Videos
Staging of bronchiolitis obliterans syndrome using home spirometry
S M Finkelstein1, M Snyder, C E Stibbe
1Division of Health Computer Sciences, University of Minnesota, Minneapolis 55455, USA. stan@email.labmed.umn.edu
Chest
|July 29, 1999
Summary
Home spirometry detects pulmonary decline earlier than clinic spirometry in lung transplant recipients. This method offers a reliable and safe alternative for monitoring lung function and diagnosing bronchiolitis obliterans syndrome (BOS).
Area of Science:
- Thoracic surgery
- Pulmonology
- Transplant medicine
Background:
- Bronchiolitis obliterans syndrome (BOS) is a major cause of graft dysfunction after lung transplantation.
- Early detection of pulmonary decline is crucial for managing BOS and improving patient outcomes.
Purpose of the Study:
- To compare the efficacy of home spirometry versus traditional clinic-based pulmonary function tests in detecting BOS in lung transplant recipients.
- To evaluate home spirometry as a reliable and safe monitoring tool.
Main Methods:
- A cohort of 45 lung transplant recipients participated in a home monitoring program using concurrent home and clinic spirometry.
- Subjects served as their own controls, with BOS staging determined by a home-based algorithm using FEV1 values.
- Pulmonary function decline to at least BOS stage 1 occurred in 17 subjects.
Main Results:
- Home spirometry detected BOS stage 1 an average of 276-341 days earlier than clinic spirometry.
- This earlier detection was statistically significant (p < 0.001) regardless of the persistence criteria used.
- The study demonstrated the sensitivity of home spirometry in identifying early pulmonary function decline.
Conclusions:
- Home spirometry is a valuable tool for earlier detection of pulmonary decline in lung transplant recipients.
- It serves as a safe and reliable alternative to frequent clinic-based pulmonary function testing.
- Implementing home spirometry can potentially improve the management of BOS.